Ekso Bionics Holdings, Inc. (EKSO) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 2.14M | 3.14M | 4.23M | 2.06M | 3.38M | 5.09M | 4.13M | 4.95M | 3.76M | 4.85M | 4.61M | 4.7M |
| Revenue Growth % | -36.56% | -38.31% | 2.37% | -58.44% | -10.14% | 5.01% | -10.38% | 5.25% | -8.88% | 36.5% | 38.39% | 35.73% |
| Cost of Goods Sold | 1.07M | 1.47M | 1.68M | 1.24M | 1.57M | 2.38M | 1.92M | 2.31M | 1.8M | 2.48M | 2.15M | 2.45M |
| COGS % of Revenue | 49.84% | 46.78% | 39.7% | 60.18% | 46.49% | 46.68% | 46.5% | 46.73% | 48.06% | 51.12% | 46.69% | 52.07% |
| Gross Profit | 1.07M | 1.67M | 2.55M | 819K | 1.81M | 2.71M | 2.21M | 2.64M | 1.95M | 2.37M | 2.46M | 2.25M |
| Gross Margin % | 50.16% | 53.22% | 60.3% | 39.82% | 53.51% | 53.32% | 53.5% | 53.27% | 51.94% | 48.88% | 53.31% | 47.93% |
| Gross Profit Growth % | -40.53% | -38.43% | 15.39% | -68.94% | -7.43% | 14.56% | -10.06% | 16.99% | -2.45% | 41.18% | 45.67% | 37.36% |
| Operating Expenses | 6.69M | 6.18M | 3.95M | 4.79M | 5.25M | 4.94M | 4.85M | 4.97M | 5.21M | 5.82M | 5.39M | 6.54M |
| OpEx % of Revenue | 312.56% | 196.82% | 93.47% | 233.06% | 155.44% | 97.13% | 117.41% | 100.44% | 138.63% | 120.03% | 116.93% | 139.02% |
| Selling, General & Admin | 6.11M | 5.54M | 3.4M | 3.94M | 4.26M | 4.1M | 4.07M | 3.86M | 4.07M | 4.5M | 4.23M | 5.14M |
| SG&A % of Revenue | 285.33% | 176.4% | 80.46% | 191.64% | 126.16% | 80.53% | 98.6% | 77.9% | 108.39% | 92.94% | 91.77% | 109.29% |
| Research & Development | 583K | 641K | 550K | 852K | 988K | 845K | 777K | 1.12M | 1.14M | 1.31M | 1.16M | 1.4M |
| R&D % of Revenue | 27.23% | 20.41% | 13.01% | 41.42% | 29.27% | 16.6% | 18.82% | 22.55% | 30.24% | 27.09% | 25.16% | 29.73% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -30K |
| Operating Income | -5.62M | -4.51M | -1.4M | -3.98M | -3.44M | -2.23M | -2.64M | -2.33M | -3.26M | -3.45M | -2.93M | -4.28M |
| Operating Margin % | -262.4% | -143.6% | -33.17% | -193.24% | -101.93% | -43.81% | -63.91% | -47.17% | -86.69% | -71.16% | -63.62% | -91.09% |
| Operating Income Growth % | -63.31% | -102.2% | 46.87% | -70.24% | -5.65% | 35.34% | 9.96% | 45.49% | 26.8% | 22.25% | 19.79% | -32.67% |
| EBITDA | -5.62M | -4.06M | -1.03M | -3.6M | -3.92M | -1.83M | -2.23M | -1.94M | -2.85M | -2.77M | -2.59M | -4.02M |
| EBITDA Margin % | -262.4% | -129.24% | -24.49% | -174.91% | -116.06% | -35.99% | -54.06% | -39.15% | -75.88% | -57.23% | -56.2% | -85.41% |
| EBITDA Growth % | -43.43% | -121.51% | 53.63% | -85.66% | -37.44% | 33.96% | 13.79% | 51.75% | 29.35% | 33.65% | 25.75% | -33.99% |
| D&A (Non-Cash Add-back) | 0 | 451K | 367K | 377K | -477K | 398K | 407K | 397K | 406K | 675K | 342K | 267K |
| EBIT | 0 | -4.21M | -1.4M | -2.64M | -2.96M | -3.35M | -1.99M | -2.34M | -3.37M | -3.15M | -3.3M | -4.17M |
| Net Interest Income | 0 | -464K | -18K | -65K | -72K | -59K | -79K | -74K | -57K | -66K | -64K | -61K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | -143K | 464K | 18K | 65K | 72K | 59K | 79K | 74K | 57K | 66K | 64K | 61K |
| Other Income/Expense | -1.27M | -165K | -19K | 1.27M | 549K | -1.18M | 567K | -81K | -173K | 235K | -434K | 54K |
| Pretax Income | -6.88M | -4.67M | -1.42M | -2.71M | -2.89M | -3.41M | -2.07M | -2.42M | -3.43M | -3.21M | -3.37M | -4.23M |
| Pretax Margin % | -321.58% | -148.85% | -33.62% | -131.7% | -85.66% | -67.05% | -50.18% | -48.81% | -91.29% | -66.31% | -73.04% | -89.94% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -6.88M | -4.67M | -1.42M | -2.71M | -2.89M | -3.41M | -2.07M | -2.42M | -3.43M | -3.21M | -3.37M | -4.23M |
| Net Margin % | -321.58% | -148.85% | -33.62% | -131.7% | -85.66% | -67.05% | -50.18% | -48.81% | -91.29% | -66.31% | -73.04% | -89.94% |
| Net Income Growth % | -138.15% | -36.95% | 31.42% | -12.13% | 15.69% | -6.19% | 38.42% | 42.88% | 21.87% | -1.13% | 21.82% | -42.04% |
| Net Income (Continuing) | -6.88M | -4.67M | -1.42M | -2.71M | -2.89M | -3.41M | -2.07M | -2.42M | -3.43M | -3.21M | -3.37M | -4.23M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.04 | -1.57 | -0.54 | -1.24 | -0.11 | -0.14 | -0.10 | -0.13 | -0.20 | -0.22 | -0.24 | -0.31 |
| EPS Growth % | -1754.55% | -1021.43% | -440% | -853.85% | 45% | 36.36% | 58.33% | 58.06% | 37.5% | -37.5% | 36.84% | -47.62% |
| EPS (Basic) | -2.04 | -1.57 | -0.54 | -1.24 | -0.11 | -0.14 | -0.10 | -0.13 | -0.20 | -0.22 | -0.24 | -0.31 |
| Diluted Shares Outstanding | 3.56M | 2.43M | 2.62M | 2.18M | 25.39M | 24.64M | 20.31M | 18.22M | 17.42M | 14.45M | 14.07M | 13.64M |
| Basic Shares Outstanding | 3.56M | 2.43M | 2.62M | 2.18M | 25.39M | 24.64M | 20.31M | 18.22M | 17.42M | 14.45M | 14.07M | 13.64M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |